Human papillomavirus16 variant E7 gene induces transformation of NIH 3T3 cells via up-regulation of cdc25A and cyclin A

International Journal of Gynecological Cancer

Volumn 19, Issue 4, 2009, Pages 494-499

  Gao, Guifang ^a   Peng, Min ^a   Zhu, Liqin ^a   Wei, Yun ^a   Wu, Xin Xing ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Cervical cancer; E7.16; HBE7.16; HPV; Transformation

Indexed keywords

CELL CYCLE PROTEIN; CELL CYCLE PROTEIN 25A; CYCLIN A; CYCLIN E; UNCLASSIFIED DRUG; CDC25A PROTEIN, MOUSE; MESSENGER RNA; ONCOGENE PROTEIN E7, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOPROTEIN; PROTEIN TYROSINE PHOSPHATASE;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; CELL ACTIVITY; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL STRAIN 3T3; CELL TRANSFORMATION; CODON; CONTROLLED STUDY; GENE MUTATION; GENETIC TRANSFORMATION; GENETIC VARIABILITY; HEMOGLOBIN SYNTHESIS; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UTERINE CERVIX CANCER; ANIMAL; BIOSYNTHESIS; GENETIC TRANSFECTION; GENETICS; MOUSE; TRANSCRIPTION INITIATION; UPREGULATION; VIRUS CELL TRANSFORMATION;

ANIMALS; CDC25 PHOSPHATASES; CELL TRANSFORMATION, VIRAL; CYCLIN A; G1 PHASE; HUMANS; MICE; NIH 3T3 CELLS; ONCOGENE PROTEINS, VIRAL; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; S PHASE; TRANSCRIPTIONAL ACTIVATION; TRANSFECTION; UP-REGULATION;

EID: 67651055492     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e3181a39c45     Document Type: Article

References (22)

1. Quint WG, Pagliusi SR, Lelie N, et al. Results of the first World Health Organization international collaborative study of detection of human papillomavirus DNA. J Clin Microbiol. 2006;44:571-579.
2. Flores ER, Allen-Hoffmann BL, Lee D, et al. The human papillomavirus type 16 E7 oncogene is required for the productive stage of the viral life cycle. J Virol. 2000;74:6622-6631.
3. Nquven DX, Westbrook TF, McCance DJ. Human papillomavirus type 16 E7 maintains elevated levels of the cdc25A tyrosine phosphatase during deregulation of cell cycle arrest. J Virol. 2002;76:619-632.
4. Cam H, Dynlacht BD. Emerging roles for E2F: beyond the G1/S transition and DNA replication. Cancer Cell. 2003;3:311-316.
5. Zhang HS, Gavin M, Dahiya A, et al. Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF. Cell. 2000;101:79-89.
6. Balsitis SJ, Sage J, Duensing S, et al. Recapitulation of the effects of the human papillomavirus type 16 E7 oncogene on mouse epithelium by somatic Rb deletion and detection of pRb-independent effects of E7 in vivo. Mol Cell Biol. 2003;23:9094-9103.
7. Dyson N, Guida P, Munger K, et al. Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins. J Virol. 1992;66:6893-6902.
8. Phelps WC, Munger K, Yee CL, et al. Structure-function analysis of the human papillomavirus type 16 E7 oncoprotein. J Virol. 1992;66:2418-2427.
9. Martin LG, Demers GW, Galloway DA. Disruption of the G1/S transition in human papillomavirus type 16 E7-expressing human cells is associated with altered regulation of cyclin E. J Virol. 1998;72:975-985.
10. Zhang B, Chen W, Roman A. The E7 proteins of low-and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradation. Proc Natl Acad Sci U S A. 2006;103:437-442.
11. Storey A, Almond N, Osborn K, et al. Mutations of the human papillomavirus type 16 E7 gene that affect transformation, transactivation and phosphorylation by the E7 protein. J Gen Virol. 1990;71:965-970.
12. Li H, Zhao M, Qiu X, et al. Characterization of a new type HPV16 E7 variant isolated from cervical cancer highest incidence area in Hubei Province of China. Eksp Onkol. 2004;26:48-54.
13. Hickman ES, Picksley SM, Vousden KH. Cells expressing HPV16 E7 continue cell cycle progression following DNA damage induced p53 activation. Oncogene. 1994;9:2177-2181.
14. Brockman JA, Scherer DC, McKinsey TA, et al. Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation. Mol Cell Biol. 1995;15:2809-2818.
15. Traenckner EB, Pahl HL, Henkel T, et al. Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli. EMBO J. 1995;14:2876-2883.
16. Jones DL, Munger K. Analysis of the p53-Mediated G1 Growth Arrest Pathway in Cells expressing the human papillomavirus type 16 E7 oncoprotein. J Virol. 1997;71:2905-2912.
17. Demers GW, Espling E, Harry JB, et al. Abrogation of growth arrest signals by human papillomavirus type 16E7 is mediated by sequences required for transformation. J Virol. 1996;70:6862-6869.
18. Kin YT, Zhao M. Aberrant cell cycle regulation in cervical carcinoma. Yonsei Med J. 2005;46:597-613.
19. Viallard JF, Lacombe F, Belloc F, et al. Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology. Cancer Radiother. 2001;5:109-129.
20. Krek W, Ewen ME, Shirodkar S, et al. Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase. Cell. 1994;78:161-172.
21. Blomberg I, Hoffmann I. Ectopic expression of Cdc25A accelerates the G1/S transition and leads to premature activation of cyclin E-and cyclin A-dependent kinases. Mol Cell Biol. 1999;19:6183-6194.
22. Nilsson I, Hoffmann I. Cell cycle regulation by the Cdc25 phosphatase family. Prog Cell Cycle Res. 2000;4:107-114.